130 related articles for article (PubMed ID: 7746714)
1. The impact of dexamethasone on hearing loss in experimental pneumococcal meningitis.
Bhatt SM; Cabellos C; Nadol JB; Halpin C; Lauretano A; Xu WZ; Tuomanen E
Pediatr Infect Dis J; 1995 Feb; 14(2):93-6. PubMed ID: 7746714
[TBL] [Abstract][Full Text] [Related]
2. Prevention of hearing loss in experimental pneumococcal meningitis by administration of dexamethasone and ketorolac.
Rappaport JM; Bhatt SM; Burkard RF; Merchant SN; Nadol JB
J Infect Dis; 1999 Jan; 179(1):264-8. PubMed ID: 9841852
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone therapy for children with bacterial meningitis. Meningitis Study Group.
Wald ER; Kaplan SL; Mason EO; Sabo D; Ross L; Arditi M; Wiedermann BL; Barson W; Kim KS; Yogov R
Pediatrics; 1995 Jan; 95(1):21-8. PubMed ID: 7770303
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone for bacterial meningitis in children.
Med Lett Drugs Ther; 1989 Jan; 31(784):6-7. PubMed ID: 2911250
[No Abstract] [Full Text] [Related]
5. Hearing loss and pneumococcal meningitis: an animal model.
Bhatt S; Halpin C; Hsu W; Thedinger BA; Levine RA; Tuomanen E; Nadol JB
Laryngoscope; 1991 Dec; 101(12 Pt 1):1285-92. PubMed ID: 1766298
[TBL] [Abstract][Full Text] [Related]
6. Time course of hearing loss in an animal model of pneumococcal meningitis.
Kesser BW; Hashisaki GT; Spindel JH; Ruth RA; Scheld WM
Otolaryngol Head Neck Surg; 1999 May; 120(5):628-37. PubMed ID: 10229585
[TBL] [Abstract][Full Text] [Related]
7. Limited efficacy of adjuvant therapy with dexamethasone in preventing hearing loss due to experimental pneumococcal meningitis in the infant rat.
Coimbra RS; Loquet G; Leib SL
Pediatr Res; 2007 Sep; 62(3):291-4. PubMed ID: 17622952
[TBL] [Abstract][Full Text] [Related]
8. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use.
Arditi M; Mason EO; Bradley JS; Tan TQ; Barson WJ; Schutze GE; Wald ER; Givner LB; Kim KS; Yogev R; Kaplan SL
Pediatrics; 1998 Nov; 102(5):1087-97. PubMed ID: 9794939
[TBL] [Abstract][Full Text] [Related]
9. Early vancomycin therapy and adverse outcomes in children with pneumococcal meningitis.
Buckingham SC; McCullers JA; Luján-Zilbermann J; Knapp KM; Orman KL; English BK
Pediatrics; 2006 May; 117(5):1688-94. PubMed ID: 16651325
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of dexamethasone on hearing ability in children with pneumococcal meningitis.
Ozen M; Kanra G; Kara A; Ataş A; Seçmeer G; Ceyhan M; Cengiz AB; Belgin E
Turk J Pediatr; 2008; 50(1):23-9. PubMed ID: 18365587
[TBL] [Abstract][Full Text] [Related]
11. Electron microscopic temporal bone histopathology in experimental pneumococcal meningitis.
Rappaport JM; Bhatt SM; Kimura RS; Lauretano AM; Levine RA
Ann Otol Rhinol Laryngol; 1999 Jun; 108(6):537-47. PubMed ID: 10378520
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone for the treatment of children and adults with bacterial meningitis.
Girgis NI; Farid Z; Kilpatrick ME; Bishai E
Rev Infect Dis; 1990; 12(5):963-4. PubMed ID: 2237141
[No Abstract] [Full Text] [Related]
13. Otoprotective effects of dexamethasone in the management of pneumococcal meningitis: an animal study.
Kim HH; Addison J; Suh E; Trune DR; Richter CP
Laryngoscope; 2007 Jul; 117(7):1209-15. PubMed ID: 17603319
[TBL] [Abstract][Full Text] [Related]
14. The Severity of Infection Determines the Localization of Damage and Extent of Sensorineural Hearing Loss in Experimental Pneumococcal Meningitis.
Perny M; Roccio M; Grandgirard D; Solyga M; Senn P; Leib SL
J Neurosci; 2016 Jul; 36(29):7740-9. PubMed ID: 27445150
[TBL] [Abstract][Full Text] [Related]
15. Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis.
Muri L; Grandgirard D; Buri M; Perny M; Leib SL
J Neuroinflammation; 2018 Aug; 15(1):233. PubMed ID: 30131074
[TBL] [Abstract][Full Text] [Related]
16. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
[TBL] [Abstract][Full Text] [Related]
17. Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis.
Martínez-Lacasa J; Cabellos C; Martos A; Fernández A; Tubau F; Viladrich PF; Liñares J; Gudiol F
J Antimicrob Chemother; 2002 Mar; 49(3):507-13. PubMed ID: 11864951
[TBL] [Abstract][Full Text] [Related]
18. Hearing impairment in childhood bacterial meningitis is little relieved by dexamethasone or glycerol.
Peltola H; Roine I; Fernández J; González Mata A; Zavala I; Gonzalez Ayala S; Arbo A; Bologna R; Goyo J; López E; Miño G; Dourado de Andrade S; Sarna S; Jauhiainen T
Pediatrics; 2010 Jan; 125(1):e1-8. PubMed ID: 20008417
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group.
Schaad UB; Lips U; Gnehm HE; Blumberg A; Heinzer I; Wedgwood J
Lancet; 1993 Aug; 342(8869):457-61. PubMed ID: 8102428
[TBL] [Abstract][Full Text] [Related]
20. Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitis.
Muri L; Le ND; Zemp J; Grandgirard D; Leib SL
J Neuroinflammation; 2019 Jul; 16(1):156. PubMed ID: 31351490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
